AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2025

Aug 18, 2025

32870_dirs_2025-08-18_186444fe-3358-47e8-ac56-6acbecb03f08.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2025-08-15

Reporting Person: Zoon Kathryn C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-15	Common Stock	S	7086	$8.87	Disposed	71799	Direct

Footnotes

F1: Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated May 16, 2025, for the purpose of satisfying tax obligations relating
to the vesting of RSUs on May 22, 2025 and May 25, 2025, respectively.

F2: All shares sold at an exact price of $8.87.